Dr. Berlin is the co-PI of the GI
Cancer SPORE and co-PI of project 2 of the GI SPORE.
Dr. Beauchamp has two active R01 grants from NCI, and is a co-leader of Project 3 in the GI
Cancer SPORE.
Since 2002, he has directed the NCI - funded Vanderbilt Breast
Cancer SPORE where he co-leads several investigator - initiated clinical trials.
Administratively, she directs the Clinical Core of the VICC Breast
Cancer SPORE.
She has intensively worked in translational projects related to targeted therapies in breast cancer, obtaining a Pilot Project from the Breast
Cancer SPORE in 2005.
Integrate the CEP investigators into existing Endometrial
Cancer SPORE projects, with the aim of ultimately developing an independent research program in endometrial cancer.
Not exact matches
This work was supported by the Carney Family Charitable Foundation, the National
Cancer Institute's
SPORE in Breast
Cancer at Dana - Farber / Harvard
Cancer Center (grant P50CA168504), STIMIT Corporation, and the Claudia Adams Barr Program for Innovative
Cancer Research.
The research was supported by the National
Cancer Institute, Specialized Programs of Research Excellence (
SPORE) grant, National Institutes of Health, the Dermatology Foundation, the Children's Tumor Foundation, and the Burroughs Wellcome Fund.
The research team includes investigators from Mayo Clinic in Florida and Mayo Clinic
SPORE in Pancreatic
Cancer, one of three cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Inst
Cancer, one of three
cancer centers in the U.S. to receive a Specialized Program of Research Excellence (SPORE) grant for pancreatic cancer from the National Cancer Inst
cancer centers in the U.S. to receive a Specialized Program of Research Excellence (
SPORE) grant for pancreatic
cancer from the National Cancer Inst
cancer from the National
Cancer Inst
Cancer Institute.
This research was supported by grants from the National Institutes of Health (CA038548, CA140599, CA179991, CA180682), and by the AACR Pancreatic
Cancer Action Network, Vanderbilt GI
SPORE and Vanderbilt - Ingram
Cancer Center.
Health and Medicine Reporter Research AACR Pancreatic
Cancer Action Network featured - Reporter gi spore Nature Genetics NCI NIH Oliver McDonald pancreatic cancer pathology microbiology and immunology Reporter Jan 20 2017 Vanderbilt Ingram Cancer
Cancer Action Network featured - Reporter gi
spore Nature Genetics NCI NIH Oliver McDonald pancreatic
cancer pathology microbiology and immunology Reporter Jan 20 2017 Vanderbilt Ingram Cancer
cancer pathology microbiology and immunology Reporter Jan 20 2017 Vanderbilt Ingram
Cancer Cancer Center
Study groups were drawn from the Icelandic
Cancer Registry; CAPS1, a population - based study of prostate cancer patients in Sweden; the Prostate Cancer Specialized Program of Research Excellence (SPORE) at Northwestern University; and the Flint Men's Health Study and the Prostate Cancer Genetics Project, both of the University of Mic
Cancer Registry; CAPS1, a population - based study of prostate
cancer patients in Sweden; the Prostate Cancer Specialized Program of Research Excellence (SPORE) at Northwestern University; and the Flint Men's Health Study and the Prostate Cancer Genetics Project, both of the University of Mic
cancer patients in Sweden; the Prostate
Cancer Specialized Program of Research Excellence (SPORE) at Northwestern University; and the Flint Men's Health Study and the Prostate Cancer Genetics Project, both of the University of Mic
Cancer Specialized Program of Research Excellence (
SPORE) at Northwestern University; and the Flint Men's Health Study and the Prostate
Cancer Genetics Project, both of the University of Mic
Cancer Genetics Project, both of the University of Michigan.
We are part of a National
Cancer Institute - funded Specialized Programs of Research Excellence (
SPORE) grant and participate in Children's Oncology Group and internal lymphoma studies within Texas Children's
Cancer Center and the Cell and Gene Therapy Program.
To date, the program has received $ 23 million in grant support from the National
Cancer Institute's Specialized Programs of Research Excellence (
SPORE) Grant and NY Stem Cell Science program (NYSTEM).
She has also obtained a Breast
Cancer Research Foundation American Association for Cancer Research (BCRF - AACR) Grant for Translational Breast Cancer Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Dire
Cancer Research Foundation American Association for
Cancer Research (BCRF - AACR) Grant for Translational Breast Cancer Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Dire
Cancer Research (BCRF - AACR) Grant for Translational Breast
Cancer Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Dire
Cancer Research to explore combined endocrine and ErbB inhibition in ER + / HER2 + breast
cancers in 2007, a K23 Career Development Award to explore targeted therapies in breast
cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Dire
cancer, and is also co-Leader in three of the four research projects of the NCI - funded Vanderbilt Breast
Cancer Specialized Program of Research Excellence (SPORE; Carlos Arteaga, Dire
Cancer Specialized Program of Research Excellence (
SPORE; Carlos Arteaga, Director).
To help this initiative, the GI
SPORE successfully competed its first pancreas
cancer - specific Pilot Project Award and supported a retreat in 2014.
He is the principal investigator of an NCI - funded, multi-million-dollar Specialized Program of Research Excellence (
SPORE) in ovarian
cancer, and he is the principal investigator of a multi-million-dollar grant from the New York State Stem Cell Science program (NYSTEM) to pioneer a novel strategy of reprogramming human mature T cells and hematopoietic stem cells for generating sustained attack against ovarian
cancer in patients.
The Breast
SPORE Developmental Research Program provides pilot funding to promote excellent translational research in breast
cancer.
1993 The Johns Hopkins
Cancer Center is awarded a record three SPORE grants for lung, gastrointestinal, and prostate cancer res
Cancer Center is awarded a record three
SPORE grants for lung, gastrointestinal, and prostate
cancer res
cancer research.
Steven Baylin's epigenetics research is recognized by the National
Cancer Institute as the most outstanding in its
SPORE (Specialized Program of Research Excellence).
The study, entitled «Prognostic factors modifying the treatment - free interval in recurrent ovarian
cancer,» was supported in part by Roswell Park Comprehensive Cancer Center, a grant from the Roswell Park Alliance Foundation Institute and National Institutes of Health grants P50CA159981 (SPORE award to Roswell Park and the University of Pittsburgh Cancer Institute), P30CA016056, K01LM012100, R01HG007377 and T32CA1
cancer,» was supported in part by Roswell Park Comprehensive
Cancer Center, a grant from the Roswell Park Alliance Foundation Institute and National Institutes of Health grants P50CA159981 (SPORE award to Roswell Park and the University of Pittsburgh Cancer Institute), P30CA016056, K01LM012100, R01HG007377 and T32CA1
Cancer Center, a grant from the Roswell Park Alliance Foundation Institute and National Institutes of Health grants P50CA159981 (
SPORE award to Roswell Park and the University of Pittsburgh
Cancer Institute), P30CA016056, K01LM012100, R01HG007377 and T32CA1
Cancer Institute), P30CA016056, K01LM012100, R01HG007377 and T32CA108456.
The Biomarker Sciences Program is an excellent venue to promote the interests of member
cancer centers and
SPOREs (Specialized Programs of Research Excellence), ensuring involvement by their basic and translational scientists.